Sáez Ayala M, Hoffer L, Abel S, Ben Yaala K, Sicard B, Andrieu G, et al. From a drug repositioning to a structure-based drug design approach to tackle acute lymphoblastic leukemia. Nat Commun. 2023;14:3079 pubmed publisher

Huang F, Wang H, Zhang Y, Wei G, Xie Y, Wu G. Synergistic Effect of QNZ, an Inhibitor of NF-κB Signaling, and Bone Morphogenetic Protein 2 on Osteogenic Differentiation in Mesenchymal Stem Cells through Fibroblast-Induced Yes-Associated Protein Activation. Int J Mol Sci. 2023;24: pubmed publisher

Shi P, Murphy M, Aparicio A, Kesner J, Fang Z, Chen Z, et al. Collateral activity of the CRISPR/RfxCas13d system in human cells. Commun Biol. 2023;6:334 pubmed publisher

Nakamura H, Tanaka T, Ji Y, Zheng C, Afione S, Warner B, et al. Salivary gland LAMP3 mRNA expression is a possible predictive marker in the response to hydroxychloroquine in Sjögren's disease. PLoS ONE. 2023;18:e0282227 pubmed publisher

Hezkiy E, Kumar S, Gahramanov V, Yaglom J, Hesin A, Jadhav S, et al. Search for Synergistic Drug Combinations to Treat Chronic Lymphocytic Leukemia. Cells. 2022;11: pubmed publisher

Lamamy J, Larue A, Mariot J, Dhomm xe9 e C, Demattei M, Delneste Y, et al. The neonatal Fc receptor expression during macrophage differentiation is related to autophagy. Front Immunol. 2022;13:1054425 pubmed publisher

Fragoso M, Fernández G, Vanderveer L, Cooper H, Slifker M, Clapper M. Dysregulation of miR-1-3p: An Early Event in Colitis-Associated Dysplasia. Int J Mol Sci. 2022;23: pubmed publisher

Wang Y, Elsherbiny A, Kessler L, Cordero J, Shi H, Serke H, et al. Lamin A/C-dependent chromatin architecture safeguards naïve pluripotency to prevent aberrant cardiovascular cell fate and function. Nat Commun. 2022;13:6663 pubmed publisher

Balood M, Ahmadi M, Eichwald T, Ahmadi A, Majdoubi A, Roversi K, et al. Nociceptor neurons affect cancer immunosurveillance. Nature. 2022;611:405-412 pubmed publisher

Cook M, Bradstreet T, Webber A, Kim J, Santeford A, Harris K, et al. The ZFP36 family of RNA binding proteins regulates homeostatic and autoreactive T cell responses. Sci Immunol. 2022;7:eabo0981 pubmed publisher

Cribioli E, Giordano Attianese G, Ginefra P, Signorino Gelo A, Vuillefroy de Silly R, Vannini N, et al. Enforcing GLUT3 expression in CD8+ T cells improves fitness and tumor control by promoting glucose uptake and energy storage. Front Immunol. 2022;13:976628 pubmed publisher

Li W, Jiang H, Bai C, Yu S, Pan Y, Wang C, et al. Ac2-26 attenuates hepatic ischemia-reperfusion injury in mice via regulating IL-22/IL-22R1/STAT3 signaling. Peerj. 2022;10:e14086 pubmed publisher

Catal xe0 C, Velasco de Andr xe9 s M, Leyton Pereira A, Casad xf3 Llombart S, S xe1 ez Moya M, Guti xe9 rrez C xf3 zar R, et al. CD6 deficiency impairs early immune response to bacterial sepsis. iScience. 2022;25:105078 pubmed publisher

Peeters R, Cuenca Escalona J, Zaal E, Hoekstra A, Balvert A, Vidal Manrique M, et al. Fatty acid metabolism in aggressive B-cell lymphoma is inhibited by tetraspanin CD37. Nat Commun. 2022;13:5371 pubmed publisher

Papadas A, Deb G, Cicala A, Officer A, Hope C, Pagenkopf A, et al. Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment. Cell Rep. 2022;40:111201 pubmed publisher

Schewe D, Vogiatzi F, Heymann J, Müller K, Winterberg D, Drakul A, et al. Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosis. Blood Adv. 2022;: pubmed publisher

Lei X, Lin H, Wang J, Ou Z, Ruan Y, Sadagopan A, et al. Mitochondrial fission induces immunoescape in solid tumors through decreasing MHC-I surface expression. Nat Commun. 2022;13:3882 pubmed publisher

Tan H, Wang H, Ma J, Deng H, He Q, Chen Q, et al. Identification of human LDHC4 as a potential target for anticancer drug discovery. Acta Pharm Sin B. 2022;12:2348-2357 pubmed publisher

Jin X, Li L, Peng Q, Gan C, Gao L, He S, et al. Glycyrrhetinic acid restricts mitochondrial energy metabolism by targeting SHMT2. iScience. 2022;25:104349 pubmed publisher

Leary N, Walser S, He Y, Cousin N, Pereira P, Gallo A, et al. Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes. J Extracell Vesicles. 2022;11:e12197 pubmed publisher

Krone A, Fu Y, Schreiber S, Kotrba J, Borde L, Nötzold A, et al. Ionic mitigation of CD4+ T cell metabolic fitness, Th1 central nervous system autoimmunity and Th2 asthmatic airway inflammation by therapeutic zinc. Sci Rep. 2022;12:1943 pubmed publisher

Wu L, Xu Y, Zhao H, Zhou Y, Chen Y, Yang S, et al. FcγRIIB potentiates differentiation of myeloid-derived suppressor cells to mediate tumor immunoescape. Theranostics. 2022;12:842-858 pubmed publisher

Lee A, Jin H, Masudul Haque M, Kim H, Jung H, Park J, et al. Synergism of a novel MCL‑1 downregulator, acriflavine, with navitoclax (ABT‑263) in triple‑negative breast cancer, lung adenocarcinoma and glioblastoma multiforme. Int J Oncol. 2022;60: pubmed publisher

Yao F, Deng Y, Zhao Y, Mei Y, Zhang Y, Liu X, et al. A targetable LIFR-NF-κB-LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis. Nat Commun. 2021;12:7333 pubmed publisher

Zhuo J, Lu D, Lin Z, Yang X, Yang M, Wang J, et al. The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib. Cell Death Dis. 2021;12:1084 pubmed publisher

Tang J, Chen Z, Wang Q, Hao W, Gao W, Xu H. hnRNPA2B1 Promotes Colon Cancer Progression via the MAPK Pathway. Front Genet. 2021;12:666451 pubmed publisher

Rutherford T, Elder A, Lyons T. Anoikis resistance in mammary epithelial cells is mediated by semaphorin 7a. Cell Death Dis. 2021;12:872 pubmed publisher

Singh S, Kumar S, Viswakarma N, Principe D, Das S, Sondarva G, et al. MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3. Oncogene. 2021;40:6153-6165 pubmed publisher

Wu H, Li X, Zhou C, Yu Q, Ge S, Pan Z, et al. Circulating mature dendritic cells homing to the thymus promote thymic epithelial cells involution via the Jagged1/Notch3 axis. Cell Death Discov. 2021;7:225 pubmed publisher

Zhan L, Wang X, Zhang Y, Zhu G, Ding Y, Chen X, et al. Benazepril hydrochloride protects against doxorubicin cardiotoxicity by regulating the PI3K/Akt pathway. Exp Ther Med. 2021;22:1082 pubmed publisher

Seong B, Dharia N, Lin S, Donovan K, Chong S, Robichaud A, et al. TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma. Cancer Cell. 2021;39:1262-1278.e7 pubmed publisher

Li K, Zheng X, Tang H, Zang Y, Zeng C, Liu X, et al. E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non-small cell lung cancer. J Exp Med. 2021;218: pubmed publisher

Gourvest M, De Clara E, Wu H, Touriol C, Meggetto F, de Th xe9 H, et al. A novel leukemic route of mutant NPM1 through nuclear import of the overexpressed long noncoding RNA LONA. Leukemia. 2021;35:2784-2798 pubmed publisher

Huangfu J, Hao C, Wei Z, Wormstone I, Yan H, Fan X. Cellular FLICE-like inhibitory protein (cFLIP) critically maintains apoptotic resistance in human lens epithelial cells. Cell Death Dis. 2021;12:386 pubmed publisher

Lei J, Zhou Y, Zhao H, Chen Y, Yan G, Wu L, et al. Dabigatran activates inflammation resolution by promoting fibrinogen-like protein 2 shedding and RvD5n-3 DPA production. Theranostics. 2021;11:4251-4261 pubmed publisher

Tang Q, Efe G, Chiarella A, Leung J, Chen M, Yamazoe T, et al. Mutant p53 regulates Survivin to foster lung metastasis. Genes Dev. 2021;35:528-541 pubmed publisher

Chen X, Gao A, Zhang F, Yang Z, Wang S, Fang Y, et al. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation. Theranostics. 2021;11:3392-3416 pubmed publisher

Huang Z, Zhang Q, Wang Y, Chen R, Wang Y, Huang Z, et al. Inhibition of caspase-3-mediated GSDME-derived pyroptosis aids in noncancerous tissue protection of squamous cell carcinoma patients during cisplatin-based chemotherapy. Am J Cancer Res. 2020;10:4287-4307 pubmed

Gómez Aleza C, Nguyen B, Yoldi G, Ciscar M, Barranco A, Hernandez Jimenez E, et al. Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells. Nat Commun. 2020;11:6335 pubmed publisher

Riebeling T, Jamal K, Wilson R, Kolbrink B, von Samson Himmelstjerna F, Moerke C, et al. Primidone blocks RIPK1-driven cell death and inflammation. Cell Death Differ. 2021;28:1610-1626 pubmed publisher

Tanaka T, Warner B, Odani T, Ji Y, Mo Y, Nakamura H, et al. LAMP3 induces apoptosis and autoantigen release in Sjögren's syndrome patients. Sci Rep. 2020;10:15169 pubmed publisher

Gunda V, Pathania A, Chava S, Prathipati P, Chaturvedi N, Coulter D, et al. Amino Acids Regulate Cisplatin Insensitivity in Neuroblastoma. Cancers (Basel). 2020;12: pubmed publisher

Dong Y, Bai J, Zhang Y, Zhou Y, Pan X, Li X, et al. Alpha lipoic acid promotes development of hematopoietic progenitors derived from human embryonic stem cells by antagonizing ROS signals. J Leukoc Biol. 2020;108:1711-1725 pubmed publisher

Hu M, Lu Y, Qi Y, Zhang Z, Wang S, Xu Y, et al. SRC-3 Functions as a Coactivator of T-bet by Regulating the Maturation and Antitumor Activity of Natural Killer Cells. Cancer Immunol Res. 2020;8:1150-1162 pubmed publisher

Chiarella E, Codispoti B, Aloisio A, Cosentino E, Scicchitano S, Montalcini Y, et al. Zoledronic acid inhibits the growth of leukemic MLL-AF9 transformed hematopoietic cells. Heliyon. 2020;6:e04020 pubmed publisher

Simula L, Corrado M, Accordi B, Di Rita A, Nazio F, Antonucci Y, et al. JNK1 and ERK1/2 modulate lymphocyte homeostasis via BIM and DRP1 upon AICD induction. Cell Death Differ. 2020;: pubmed publisher

Chen C, Li B, Millman S, Chen C, Li X, Morris J, et al. Vitamin B6 Addiction in Acute Myeloid Leukemia. Cancer Cell. 2020;37:71-84.e7 pubmed publisher

Dolan M, Mastri M, Tracz A, Christensen J, Chatta G, Ebos J. Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance. PLoS ONE. 2019;14:e0220101 pubmed publisher

Gong H, Liu F, Liu X, Min S, Wu N, Liu X, et al. APPBP2 enhances non-small cell lung cancer proliferation and invasiveness through regulating PPM1D and SPOP. EBioMedicine. 2019;: pubmed publisher

Xie J, Zhou Z, Jiao S, Li X. Construction of an anti-programmed death-ligand 1 chimeric antigen receptor and determination of its antitumor function with transduced cells. Oncol Lett. 2018;16:157-166 pubmed publisher

Paz H, Joo E, Chou C, Fei F, Mayo K, Abdel Azim H, et al. Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008. J Exp Clin Cancer Res. 2018;37:67 pubmed publisher

Li H, Guo A, Xie Z, Tu W, Yu J, Wang H, et al. Stabilization of mouse haploid embryonic stem cells with combined kinase and signal modulation. Sci Rep. 2017;7:13222 pubmed publisher

Broggi A, Tan Y, Granucci F, Zanoni I. IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil function. Nat Immunol. 2017;18:1084-1093 pubmed publisher

Corso J, Pan K, Walter R, Doebele C, Mohr S, Bohnenberger H, et al. Elucidation of tonic and activated B-cell receptor signaling in Burkitt's lymphoma provides insights into regulation of cell survival. Proc Natl Acad Sci U S A. 2016;113:5688-93 pubmed publisher

Fluckiger A, Dumont A, Derangère V, Rébé C, de Rosny C, Causse S, et al. Inhibition of colon cancer growth by docosahexaenoic acid involves autocrine production of TNFα. Oncogene. 2016;35:4611-22 pubmed publisher

Yin S, Mao Y, Li X, Yue C, Zhou C, Huang L, et al. Hyperactivation and in situ recruitment of inflammatory Vδ2 T cells contributes to disease pathogenesis in systemic lupus erythematosus. Sci Rep. 2015;5:14432 pubmed publisher